全身弥散加权成像在初诊多发性骨髓瘤诊断与监测中的作用
回顾性分析107例初诊多发性骨髓瘤患者,其中60例治疗前行WB-DWI检查,WB-DWI阳性检出率为95.0%(57/60),13例CT未发现骨质破坏者WB-DWI检出弥散受限病灶;8例治疗前后WB-DWI显示治疗后最大病灶中位ADC值高于治疗前,诱导治疗后WB-DWI结果与临床疗效相符。
要点
- WB-DWI对初诊MM骨破坏阳性检出率为95.0%(57/60),肋骨最易受累,检出率96.5%(55/57)。
- 13例CT未发现骨质破坏的患者,WB-DWI检出相同部位弥散受限病灶影。
- 8例治疗前后WB-DWI显示治疗后最大病灶中位ADC值高于治疗前,且均高于正常值。
核心结论
- WB-DWI在初诊MM诊断和监测中起重要作用,其诊断敏感性优于CT。
- 诱导治疗后WB-DWI检查结果与患者临床疗效有一定的相关性,可用于疾病监测。
研究设计与样本
- 回顾性分析2012年9月至2016年1月苏州大学附属第一医院血液科收治的107例初诊MM患者临床资料。
- 分析其中治疗前行WB-DWI检查的60例患者结果,探讨WB-DWI在MM诊断和监测中的作用。
主要发现
- 60例中57例发现程度不等的骨质破坏病灶,WB-DWI阳性检出率为95.0%(57/60)。
- MM相关骨破坏多累及中轴骨,以肋骨、脊柱及骨盆骨多见,肋骨最易受累,检出率为96.5%(55/57)。
- 13例初诊CT未发现骨质破坏的患者,WB-DWI发现相同部位有弥散受限病灶影。
- 8例治疗前后均行WB-DWI,治疗前最大病灶中位ADC值为0.984×10(-3)mm(2)/s,治疗后为1.142×10(-3)mm(2)/s,治疗后较治疗前高,且均高于正常值[(0.516±0.180)×10(-3)mm(2)/s]。
- 诱导治疗后WB-DWI检查结果与临床疗效相符。
临床怎么用
- 原文结论认为WB-DWI在初诊MM诊断和监测中起重要作用,诊断敏感性优于CT,诱导治疗后结果与临床疗效有一定相关性,可用于疾病监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the practical value of whole-body diffusion weighted imaging (WB-DWI) in the diagnosis and monitoring of newly diagnosed multiple myeloma (MM) patients. Methods: The clinical data of 107 newly diagnosed MM patients at hematology department of the first affiliated hospital of Soochow's University from September 2012 to January 2016 were retrospectively analyzed. The results of all the 60 patients who were performed WB-DWI before treatment were analyzed. And the role of WB-DWI in the diagnosis and monitoring MM was discussed. Results: Of 60 patients, 57 were found to have more or less abnormal foci of osteoclasia by WB-DWI with the positive rate of 95.0% (57/60) . Myeloma related bone lesions occurred predominantly in the axial skeleton, which were commonly seen in ribs, spines and pelvis. There were 96.5% (55/57) patients who had osteolytic rib lesions. And the ribs were the most vulnerable organs. Thirteen patients who had no osteoclasia by computerized tomography (CT) examination were detected abnormal limited diffuse lesions by WB-DWI. Eight patients underwent more than one follow-up WB-DWI. The mean apparent diffusion coefficient (ADC) values of the maximal lesions from all eight patients before and after treatment were 0.984×10(-3)mm(2)/s and 1.142×10(-3)mm(2)/s, respectively. They were both higher than the normal range [ (0.516±0.180) ×10(-3)mm(2)/s]. Mean ADC values of the maximal lesions after treatment were higher than that before treatment. The results of WB-DWI after the induction chemotherapy were consistent with clinical therapeutic effect. Conclusions: WB-DWI has an important value in the diagnosis and monitoring of newly diagnosed MM. It has higher sensitivity than than that of CT. The results of WB-DWI after induction therapy has a nice correlation with treatment effect and it could monitor the disease. 目的:探讨磁共振全身弥散加权成像(WB-DWI)在初诊多发性骨髓瘤(MM)患者诊断和监测中的应用价值。 方法:收集2012年9月至2016年1月收治的107例初诊MM患者的临床资料,分析其中治疗前行WB-DWI检查的60例患者的结果,探讨WB-DWI在MM诊断和监测中的作用。 结果: 60例患者中有57例均发现程度不等的骨质破坏病灶,WB-DWI阳性检出率为95.0%(57/60)。MM相关的骨破坏多累及中轴骨,以肋骨、脊柱及骨盆骨多见,肋骨为最易受累部位,检出率为96.5%(55/57)。有13例患者初诊时CT检查未发现骨质破坏,但行WB-DWI检查发现相同部位有弥散受限病灶影。8例患者治疗前后均行WB-DWI检查,结果显示8例患者治疗前最大病灶的中位表观弥散系数(ADC)值为0.984×10(-3)mm(2)/s;治疗后为1.142×10(-3)mm(2)/s,治疗后最大病灶的中位ADC值较治疗前高,且均高于正常值[(0.516±0.180)×10(-3)mm(2)/s];诱导治疗后WB-DWI检查结果与临床疗效相符。 结论: WB-DWI在诊断和监测MM中起重要作用,其诊断敏感性优于CT;诱导治疗后的WB-DWI检查结果与患者的临床疗效有一定的相关性,可用于疾病监测。.
引用
- Wang PF, Li YC, Xu Y, et al. [Role of whole-body diffusion weighted imaging (WB-DWI) in the diagnosis and monitoring of newly diagnosed multiple myeloma]. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28279037. doi:10.3760/cma.j.issn.0253-2727.2017.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。